Related Experiment Videos
The clinical value of HbAI-determinations
Acta Medica Scandinavica. Supplementum
|January 1, 1980
Summary
Glycosylated hemoglobin (HbA1c) testing offers valuable insights into long-term blood glucose control for diabetic patients. This microchromatographic method is suitable for routine clinical use, aiding in diabetes management.
Area of Science:
- Clinical Chemistry
- Endocrinology
Background:
- Glycosylated hemoglobin (HbA1c) reflects average blood glucose over time.
- Accurate monitoring is crucial for managing diabetes.
Purpose of the Study:
- To evaluate a microchromatographic method for HbA1c determination.
- To assess the utility of HbA1c in routine diabetes care.
Main Methods:
- Microchromatographic procedure for HbA1c analysis.
- Analysis of HbA1c levels in healthy subjects and diabetic patients.
Main Results:
- HbA1c in healthy subjects: 6.5 +/- 0.8%.
- HbA1c in diabetic patients: 9.6 +/- 1.8%.
- HbA1c is particularly useful for insulin-treated diabetics with glucose variability.
Conclusions:
- Microchromatographic HbA1c determination is suitable for routine clinical work.
- HbA1c is a valuable tool for assessing carbohydrate status in diabetics.
- Further research is needed to refine HbA1c interpretation due to influencing factors like erythrocyte survival and renal function.